Trial Profile
Evaluation of the safety and immunogenicity of combined pentavalent vaccine DPT-HB-Hib, liquid, in healthy suckling children according to a schedule of administration at 6-10-14 weeks of age. Open and randomized clinical trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Hib-DTP-hepatitis B vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
- Focus Adverse reactions
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry.
- 23 Sep 2011 New trial record